CTRI Registration: Step-by-Step Process, Dataset, Verification and Timelines

The Clinical Trials Registry – India (CTRI) publishes its dataset fields and an FAQ, but it does not publish a single consolidated walk-through of the registration workflow — what you do first, what blocks submission, who has to click what, and how long each stage actually takes. This guide assembles that workflow from CTRI’s own pages and ICMR’s registration-guidance portal, and is explicit about the points where CTRI publishes no figure at all rather than filling the gap with an estimate.

Two framings circulate widely in secondary write-ups and are wrong on the primary source; both are corrected below. The CTRI dataset is not a three-part form — it has eight parts. And CTRI does not operate a formal named “verifier” role — what exists is an email confirmation step performed by the trial’s own declared contact persons.

Verified 26 August 2026 against CTRI’s own FAQ and applicant login pages (ctri.nic.in) and ICMR’s CTRI registration-guidance portal (ctri.icmr.org.in). Points that could not be verified are flagged as such in the text.

What CTRI registration is — and what it is not

CTRI registration is a public-record step, not a regulatory permission step. Registering a trial in CTRI does not authorise you to run it, and CTRI does not review the science or the ethics of your study. It records the trial in India’s national registry so the study exists on the public record before participants are enrolled.

The authorisation that lets a trial proceed is separate and comes from India’s Central Drugs Standard Control Organisation via the Drugs Controller General of India, plus a registered Ethics Committee. CASRAI’s guide to the CDSCO clinical trial approval pathway covers that side; this page covers only the registry workflow. The practical consequence for a study start-up timeline is that these are sequential, not parallel: CTRI requires the approvals as an input, so registration cannot begin in earnest until the approvals you need are in hand.

For the definitional background — CTRI’s launch, governance, statutory basis and identifier format — see the CASRAI Dictionary entry for CTRI (Clinical Trials Registry – India). This guide assumes that context and stays on procedure.

Before you start: the three prerequisites

CTRI’s FAQ is unambiguous that registration is gated on documents you must already hold. Attempting to work around any of these is the single most common reason a submission stalls.

1. Ethics Committee approval. CTRI states that “submission/upload of ethics approval is mandatory for registration.” There is no route that defers this to later.
2. DCGI approval, where applicable. CTRI states that “submission of approval from the DCGI, wherever applicable, is also mandatory.” Note the qualifier — this is conditional, not universal. Many studies CTRI registers (observational studies, academic studies not involving a new drug, and most postgraduate thesis studies) require no DCGI permission at all, and for those the requirement simply does not bite. Do not read this as “every CTRI registration needs a DCGI approval letter.”
3. No participant enrolled yet. The applicant declaration on CTRI’s own submission interface requires you to affirm that “no participant has been enrolled in the clinical trial prior to registration with the Clinical Trials Registry – India (CTRI).” This is a hard gate, not a formality — see the prospective-registration section below.

Step 1 — Create the applicant account

Trial registration in CTRI is a two-tier process: you first register yourself as a user, then register the trial under that account. Per CTRI’s FAQ, the account step runs as follows:

• Complete the NEW USER form on the CTRI homepage and submit it online.
• CTRI sends a confirmation email containing your username and password.
• The account is activated only on receipt of a second confirmatory email — the first email issues the credentials, the second activates them. An applicant who receives credentials and finds they do not work has usually not completed this second step.

Plan for this to be a real, if short, dependency. The account is per-applicant, and one applicant account can carry multiple trials, so an institution registering several studies does not need a fresh account each time.

Step 2 — Fill the dataset: eight parts, not three

The trial registration dataset is entered online through a form divided into eight parts. Two structural rules govern how you fill them:

• Part 1 must be completed first. The remaining parts may then be filled in whatever order is convenient to the user.
• The trial cannot be submitted until every dataset point is filled. This completeness check was introduced deliberately in the registry’s revised version to ensure complete trial information is recorded — so there is no partial-submission route where missing fields get resolved during review.

The dataset carries the 20 items of the WHO Trial Registration Data Set plus additional CTRI-specific items, covering the substance you would expect: public and scientific title, sponsor and funding, the trial’s registered Ethics Committee, health condition studied, intervention and comparator details, inclusion and exclusion criteria, primary and secondary outcomes, target sample size, recruitment status and sites, and the contact persons described in Step 3.

CTRI’s FAQ also records an important simplification: “currently the trial registration data set is same for all types of clinical studies.” There is no reduced dataset for observational studies, academic studies, or thesis work — the form is the form.

What this guide does not claim: we have not independently verified the exact field-by-field contents of Parts 2 through 8, so no per-part field list is given here. ICMR publishes dedicated “how to fill part N” guidance pages for each of the eight parts on its CTRI portal at ctri.icmr.org.in, and that is the authority to work from field-by-field — not a secondary summary, including this one.

Step 3 — Contact-person email confirmation (the “verifier” question)

Secondary guides frequently describe a CTRI “verifier” as though it were a defined institutional office-holder role, comparable to a signing official. On CTRI’s own FAQ, no separate named verifier role is defined. What CTRI actually operates is an email verification and confirmation-of-participation step performed by the trial’s own declared contact persons.

Those contact persons are the ones the dataset itself asks you to name:

• the overall trial Principal Investigator;
• the contact person for scientific queries;
• the contact person for public queries.

CTRI emails these individuals at the addresses given in the dataset, and each must respond from that designated address to confirm their participation in the trial. This has three practical consequences that are worth planning around:

1. The email addresses in the dataset must be real, monitored, individual mailboxes. A shared departmental alias, a defunct address from a previous posting, or a mistyped address does not just look untidy — it stops registration, because the confirmation cannot be returned from it.
2. You are dependent on other people’s inboxes. The named individuals must actually see and answer the CTRI email. Where the PI is senior, travelling, or externally affiliated, this is routinely the slowest link in the chain, and it is entirely outside the applicant’s control.
3. Brief them before you submit, not after. Telling each named contact that a confirmation email is coming, and from where, converts a multi-week stall into a same-day step.

So the honest answer to “who can act as the verifier” is: not a designated official, but the specific people you name in the dataset as PI and as scientific and public contacts — which means the choice of those names is itself a scheduling decision.

Step 4 — Submission, reference number, and review

Once all eight parts are complete, the trial is submitted and receives a reference number, which is distinct from the final registration number. The reference number identifies the application while it is in process; the permanent CTRI identifier in the format CTRI/YYYY/MM/NNNNNN is issued only on successful registration.

CTRI then reviews the submission and, in the normal course, sends it back to the registrant with clarifications or modifications to address. Being sent back is the expected path, not an adverse outcome. ICMR maintains dedicated guidance on updating trials that have been returned after review. The applicant incorporates the modifications, uploads any outstanding approvals, ensures the contact-person confirmations have been received, and resubmits.

Timelines: what CTRI publishes, and what it does not

This is where most secondary write-ups substitute an estimate for a source. CTRI publishes exactly one figure:

“Upon submission of a study to the CTRI, it is reviewed within 10 working days.”

That is a first-review service level, not an end-to-end registration time. CTRI is explicit that total time to registration is heavily dependent on the registrant: the sooner modifications are incorporated, approvals uploaded, verification received and the trial resubmitted, the faster registration completes.

CTRI does not publish a total end-to-end turnaround time, a target number of review rounds, or a service level for re-review after resubmission. We could not verify any such figure against a primary source, and this guide therefore does not give one. Any specific “CTRI takes X weeks” claim you encounter should be treated as an author’s experience rather than a published commitment. For planning purposes, the defensible statement is: budget for a 10-working-day first review, at least one round of modifications, and however long your named contact persons take to answer their email — the last of which is usually the variable that actually determines the date.

Fees: there are none

CTRI’s FAQ answers this directly: “No, there are no fees for registering trials in the CTRI.” CTRI’s own login page describes the registry as “a free and online public record system for registration of clinical trials.” This applies to all study types, including commercially sponsored trials — there is no tiered or sponsor-based fee schedule. Registration cost is staff time, not a registry charge.

Prospective registration: the rule and its full reach

CTRI requires registration to occur prospectively — before the enrolment of the first patient into the study. The applicant declaration makes this an affirmative statement by the registrant, and CTRI’s login interface warns that non-compliance can result in the applicant’s account being frozen and the matter reported to the relevant authorities. This is a materially sharper enforcement posture than a registry that simply flags a record as retrospectively registered.

The reach of the rule is wider than most people assume, and this is the detail most often missed. CTRI extends prospective registration beyond interventional enrolment:

“Even retrospective data collection studies should be registered before the initiating data collection.”

In other words, a chart-review or records-based study is not exempt because nobody is being enrolled. The trigger for a retrospective data-collection study is the start of data collection, and registration must precede it. A team that reads “retrospective study” as “outside the prospective-registration rule” has misread it.

The consequence downstream is publication eligibility. Registration in a WHO ICTRP primary registry before first enrolment is what satisfies the ICMJE condition for consideration by member journals, and a trial that missed the window cannot retroactively acquire compliant registration. See prospective clinical trial registration for the underlying norm and clinical trial registration and reporting compliance for how registration and results-reporting obligations differ.

The postgraduate thesis route

Postgraduate thesis studies are a large share of CTRI’s registrations and the source of most first-time applicant confusion. The position on CTRI’s own pages is straightforward:

• CTRI states that “clinical studies as part of PG thesis are also expected to be registered in the CTRI,” and its FAQ confirms that clinical studies conducted as part of a post-graduate thesis are registered in the registry.
• There is no separate, lighter PG thesis route. CTRI’s FAQ statement that the dataset “is same for all types of clinical studies” applies here — a thesis study fills the same eight-part dataset as a sponsored Phase III trial.
• The prerequisites apply unchanged: Ethics Committee approval must be uploaded, and registration must be prospective. The DCGI requirement applies only “wherever applicable,” which for most thesis studies means not at all.

The realistic implication for a PG student and supervisor is scheduling. A thesis protocol approved by the institutional Ethics Committee shortly before the intended start of data collection leaves no room for a 10-working-day first review plus a modification round plus contact-person email confirmations. Registration needs to be started when ethics approval is granted, not when data collection is due to begin. The supervisor named as PI should also expect to personally answer a CTRI confirmation email — that step cannot be delegated to the student, because the confirmation must come from the named address.

Common reasons a registration stalls

• The account was never activated — the second confirmatory email was missed at Step 1.
• An incomplete dataset — submission is blocked until all eight parts are complete, so a part left for later blocks the whole application rather than deferring one field.
• A contact person has not confirmed — the most common silent delay, because nothing visibly fails; the application simply waits.
• A wrong or unmonitored contact email address — the confirmation cannot be returned from an address nobody reads.
• Ethics approval not uploaded — mandatory in all cases, with no deferral route.
• Enrolment or data collection already begun — not a delay but a compliance failure, with account freezing and reporting to authorities as the stated consequence.

How CTRI fits the wider registry landscape

CTRI is a WHO ICTRP primary registry, so records entered in CTRI feed the global ICTRP search portal without separate registration with WHO. A trial registered in CTRI therefore satisfies ICMJE’s registration precondition on its own — registration in ClinicalTrials.gov is not additionally required for that purpose. Multi-country trials with both Indian and US-regulated sites commonly register in both, because each registry answers a different jurisdiction’s requirement, and the resulting identifiers are cross-referenced as secondary study identifiers.

CTRI plays the same structural role for India that ISRCTN plays for the UK and ChiCTR plays for China. For an orientation to registries as a category — including non-trial registries such as PROSPERO — see CASRAI’s guide to research registries, and for the equivalent US workflow, ClinicalTrials.gov registration for investigator-initiated trials. Protocol content that will populate the dataset is best settled in advance using the SPIRIT 2025 checklist. This guide sits in CASRAI’s clinical research cluster.

Frequently asked questions

How long does CTRI registration take?

CTRI publishes one figure: a submitted study “is reviewed within 10 working days.” That is a first-review service level, not an end-to-end time. CTRI states that total time depends on how quickly the registrant returns modifications, uploads approvals and obtains contact-person verification. No published end-to-end turnaround figure exists, so treat any specific total-duration claim as unsourced.

Is there a fee to register a trial in CTRI?

No. CTRI’s FAQ states there are no fees for registering trials in the CTRI, and CTRI describes itself as a free public record system. This applies to all study types including commercially sponsored trials.

How many parts does the CTRI dataset have?

Eight. Part 1 must be filled first; the remaining parts may be completed in any order. The trial cannot be submitted until every dataset point is complete. Descriptions of a “Part 1/2/3” structure are inaccurate.

Who is the verifier in CTRI registration?

CTRI does not define a separate named verifier role. It requires email confirmation of participation from the trial’s declared contact persons — the overall trial Principal Investigator, the contact person for scientific queries, and the contact person for public queries — each responding from the email address recorded in the dataset.

Can a retrospective study be registered in CTRI?

Only if registration precedes the start of data collection. CTRI states that “even retrospective data collection studies should be registered before the initiating data collection.” A records-based study is not exempt from prospective registration merely because no participants are enrolled.

Does a PG thesis study need CTRI registration?

Yes. CTRI states that clinical studies conducted as part of a post-graduate thesis are expected to be registered. There is no separate or reduced thesis route — the dataset is the same for all study types, ethics approval must be uploaded, and registration must be prospective.

Do I need DCGI approval before registering in CTRI?

Only where it applies to your study. CTRI requires DCGI approval to be submitted “wherever applicable.” Ethics Committee approval, by contrast, is mandatory for every registration with no exceptions.

Does CTRI registration mean my trial is approved?

No. CTRI is a public record system, not a regulatory authority. Approval to conduct the trial comes from a registered Ethics Committee and, where applicable, the Drugs Controller General of India through CDSCO. CTRI requires those approvals as inputs to registration.

Sources

• Clinical Trials Registry – India, Frequently Asked Questions, ctri.nic.in/Clinicaltrials/faq.php — fees, 10-working-day review, prospective-registration policy, dataset uniformity across study types, PG thesis registration, ethics and DCGI approval requirements, new-user account process, contact-person email confirmation.
• Clinical Trials Registry – India, applicant login and declaration interface, ctri.nic.in/Clinicaltrials/login.php — free public record system, no-prior-enrolment declaration, account freezing and reporting for non-compliance, PG thesis expectation.
• ICMR, CTRI trial-registration guidance portal, ctri.icmr.org.in — eight-part dataset structure, per-part filling guidance, new-applicant registration, reference-number assignment, and updating trials returned after review.
• Clinical Trials Registry – India, “The upgraded Clinical Trials Registry – India” (registry publication) — eight-part form, Part 1 first, completeness required before submission, WHO Trial Registration Data Set items plus CTRI-specific items.